← All trials
NCT05313958
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2021
- Primary completion
- Mar 30, 2026
- Completion date
- Mar 30, 2026
- First posted
- Apr 6, 2022
- Last posted
- Apr 6, 2022
- Enrollment
- 43
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Sun Yat-Sen UniversityLead sponsor
- Central South UniversityCollaborator
- Guangzhou Medical UniversityCollaborator
- Guangzhou Medical UniversityCollaborator
- Maternal and Child Health Hospital of FoshanCollaborator
- Nanchang UniversityCollaborator
- Southern Medical UniversityCollaborator
- Sun Yat-Sen UniversityCollaborator
- Sun Yat-Sen UniversityStudy chair
- Jiangxi Children's HospitalCollaborator
- Shantou UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.